LRFN4 and neoplasm: A significant positive correlation was confirmed in UCEC, CHOL, KICH, DLBC, ACC, PCPG, LAML, UCS, OV, READ, MESO, BLCA, SKCM.P, KIRC, HNSC, and KIRP (Figure 10C), suggesting LRFN4’s potential role in anti-tumor immunity through influencing the TME composition.